Veterinary Medicines

Deparvax

Authorised
  • Muscovy duck parvovirus, strain FM, Inactivated
  • Derzsy's disease virus, strain LB, Inactivated
Download as PDF

Product identification

Medicine name:
Deparvax
Deparvax, emulsja do wstrzykiwań dla kaczek piżmowych i gęsi
Active substance:
  • Muscovy duck parvovirus, strain FM, Inactivated
  • Derzsy's disease virus, strain LB, Inactivated
Target species:
  • Muscovy duck
  • Goose
Route of administration:
  • Subcutaneous use
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Muscovy duck parvovirus, strain FM, Inactivated
    7.70
    log2 virus neutralising unit(s)
    /
    0.20
    millilitre(s)
  • Derzsy's disease virus, strain LB, Inactivated
    7.90
    log2 virus neutralising unit(s)
    /
    0.20
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Muscovy duck
      • Meat and offal
        0
        day
  • Intramuscular use
    • Muscovy duck
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Goose
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01BA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • Available only in Polish
  • Available only in Polish
  • 100 ml, 250 dose, for breeder geese
  • 100ml, 500 dose for day-old or growing birds

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva-Phylaxia Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1727
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/100/001
Concerned member states:
  • Poland

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."